A study to evaluate the safety of overdose intake of plant extract materials - A study to evaluate the safety of overdose intake of plant extract materials

Clinical Creative Co., Ltd.0 个研究点目标入组 22 人开始时间: 2023年3月30日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Patients with a history of treatment for heart failure, myocardial infarction, etc. 2) Exclusion due to disease, etc. (those suffering from or undergoing treatment for atrial fibrillation, arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic disease, etc.) 3)Those whose physical measurements, physical examination values, and clinical examination values in the preliminary examination show values that are significantly out of the reference range. 4) Those who regularly use pharmaceuticals (including herbal medicines) or supplements 5) Those who have allergies (to pharmaceuticals or food related to the tested products). 6) Pregnant, lactating, or likely to become pregnant during the study period. 7) Who have participated or are currently participating in other clinical trials within one month. 8) Other subjects who are judged by the investigator to be unsuitable for this study.

发起方

Clinical Creative Co., Ltd.